22 Pulmonary Embolism Clinical Trials in Tucson, AZ (2026)

Q: How do I join a clinical trial in Tucson?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you.

Recruiting Pulmonary Embolism Studies in Tucson

NCT07064473Recruiting

A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. ...

Tucson, AZPHASE311,800 participantsBoehringer Ingelheim

View Study Details

NCT06112418Recruiting

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no k...

Tucson, AZNA7,500 participantsCleerly, Inc.

View Study Details

NCT00231400Recruiting

Pompe Disease Registry Protocol

The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's natural history and outc...

Tucson, AZ2,000 participantsGenzyme, a Sanofi Company

View Study Details

NCT07296484Recruiting

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol....

Tucson, AZPHASE21,500 participantsSparrow Pharmaceuticals

View Study Details

NCT04726241Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

This study aims to use clinical and biological characteristics of acute leukemias to screen for patient eligibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from pati...

Tucson, AZPHASE1960 participantsPedAL BCU, LLC

View Study Details

NCT07218029Recruiting

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

Researchers are looking for more ways to treat PAH. In PAH, the blood vessels in the lungs become thick and narrow, which makes it harder for blood to flow. This causes high blood pressure in the lung...

Tucson, AZPHASE3815 participantsMerck Sharp & Dohme LLC

View Study Details

NCT05099770Recruiting

Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

The purpose of this study is to assess the safety and efficacy (including durability) of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-bio...

Tucson, AZPHASE3685 participantsProkidney

View Study Details

NCT07003919Recruiting

Safety Study of Viaskin® Peanut Patch in Peanut-Allergic Children 1 Through 3 Years of Age (COMFORT Toddlers)

The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy....

Tucson, AZPHASE3480 participantsDBV Technologies

View Study Details

NCT06686121Recruiting

Improving Mobility After Revascularization in Peripheral Artery Disease

Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ische...

Tucson, AZPHASE3386 participantsNorthwestern University

View Study Details

NCT05615844Recruiting

Antibiotic Cement Bead Pouch Versus Negative Pressure Wound Therapy

The Beads vs Vac trial is a multi-centre randomized controlled trial of 312 participants with a severe open tibia fracture requiring multiple irrigation and debridement surgeries. Eligible participant...

Tucson, AZPHASE3312 participantsUniversity of Maryland, Baltimore

View Study Details

NCT07142356Recruiting

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

The goal of this clinical trial is to learn if the drug RT-001 works to reduce high blood pressure (hypertension) in adults. It will also learn about the safety of RTN-001. The main questions it aims ...

Tucson, AZPHASE2280 participantsRetension Pharmaceuticals. Inc.

View Study Details

NCT07210515Recruiting

Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)

Phase 3 Trial of AMBTX-01 (neridronate) for Complex Regional Pain Syndrome Type 1...

Tucson, AZPHASE3270 participantsAmbros Therapeutics, Inc.

View Study Details

NCT05180773Recruiting

Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy

The study will enroll 200 women newly diagnosed with peripartum cardiomyopathy within 5 months postpartum in a randomized placebo controlled trial of bromocriptine therapy to evaluate its impact on my...

Tucson, AZPHASE4250 participantsDennis M. McNamara, MD, MS

View Study Details

NCT05983250Recruiting

LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF

This study will evaluate the efficacy of TNX-103 (oral levosimendan) compared with placebo in subjects with PH-HFpEF as measured by the change in 6-Minute Walk Distance (6 MWD; Day 1 to Week 12)....

Tucson, AZPHASE3230 participantsTenax Therapeutics, Inc.

View Study Details

NCT04757116Recruiting

Post-Market Study to Assess iTind Safety in Comparison to UroLift

The study objective is to evaluate the safety of the iTind device comparied to UroLift....

Tucson, AZNA206 participantsOlympus Corporation of the Americas

View Study Details

NCT02717039Recruiting

Pharmacogenomics of Heparin-Induced Thrombocytopenia

The purpose of this research is to identify genomic markers that can predict heparin-induced thrombocytopenia (HIT), which is a very serious side effect to heparin. Heparin is commonly used to prevent...

Tucson, AZ125 participantsUniversity of Arizona

View Study Details

NCT06783309Recruiting

CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)

This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103. The approximately 208-da...

Tucson, AZPHASE172 participantsCOUR Pharmaceutical Development Company, Inc.

View Study Details

NCT07269210Recruiting

A Study of Solbinsiran (LY3561774) in Participants With Severe Hypertriglyceridemia

The purpose of this study is to evaluate the safety and efficacy of solbinsiran in lowering triglycerides and other lipid measures compared to placebo in participants with severe hypertriglyceridemia....

Tucson, AZPHASE260 participantsEli Lilly and Company

View Study Details

NCT06739122Recruiting

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

The main purpose of this study is to evaluate additional dosing options for dulaglutide in pediatric participants with Type 2 Diabetes. Participation in this study will last about 8 months....

Tucson, AZPHASE355 participantsEli Lilly and Company

View Study Details

NCT06836232Recruiting

An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis

This is a study to understand if taking VTX2735 is safe and effective in participants diagnosed with Recurrent Pericarditis (RP). Approximately 30 patients will take VTX2735. The study consists of a ...

Tucson, AZPHASE250 participantsZomagen Biosciences Ltd.

View Study Details

NCT06682949Recruiting

Daily Routines, Executive Functioning & ADHD

The goal of this clinical trial is to learn adjusting daily or nightly routines improves executive functioning in youth with ADHD. It will also learn about the acceptability of the intervention. The ...

Tucson, AZNA25 participantsCori Manning

View Study Details

NCT04062565Recruiting

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those With Advanced PAH

The purpose of this study is to determine if there is a greater effect to patients with advanced pulmonary arterial hypertension (PAH) by using a combination of two drugs, Treprostinil and Riociquat v...

Tucson, AZPHASE320 participantsUniversity of Arizona

View Study Details

About Pulmonary Embolism Clinical Trials in Tucson

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 22 pulmonary embolism clinical trials recruiting participants in Tucson, AZ. These studies are seeking a combined 28,081 participants. Research is being sponsored by Boehringer Ingelheim, Cleerly, Inc., Genzyme, a Sanofi Company and 17 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Tucson — FAQ

Are there pulmonary embolism clinical trials in Tucson?

Yes, there are 22 pulmonary embolism clinical trials currently recruiting in Tucson, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Tucson?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Tucson research site will contact you about next steps.

Are clinical trials in Tucson free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Tucson studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 22 active trials in Tucson are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 17, 2026 from ClinicalTrials.gov